News Bill Gates enters dementia research with $50m donation Fund is challenging prevailing 'amyloid hypothesis'
News Biogen sees Spinraza slow down in Q3, bullish on Alzheimer's... Biogen has given investors a pleasant surprise with better-than-expected profits in Q3, but has puzzled analysts with a rapid slowdown for its new rare disease drug Spinraza.
News Ionis to file rare disease drug after GSK declines option Firm turns down options for inotersen and IONIS-FB-LRX.
News Biogen go quantum to speed up drug development Quantum computing algorithm could lead to new neurological disease drugs.
News Biogen pays Remedy $120m to bolster stroke pipeline Acquisition provides Biogen a fall back molecule in this high risk therapy area.
News Isomorphic Labs raises $5bn in massive third round In yet another sign of the appetite for AI companies among investors, Isomorphic Labs has raised a whopping $5bn in a Series C financing.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.